Neuroscientific Biopharmaceuticals Ltd Capital Reinvestment Ratio

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd capital reinvestment ratio. Neuroscientific Biopharmaceuticals Ltd (NSB) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (AU$1.62 Million) in capital expenditures (AU$1.82K). Check NSB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Data as of

Jun 2024

Most recent filing

Capital Reinvestment Ratio of Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Capital reinvestment ratio of Neuroscientific Biopharmaceuticals Ltd from 2024 to 2024. This chart tracks Neuroscientific Biopharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Neuroscientific Biopharmaceuticals Ltd (NSB) equity growth momentum to track the company's year-over-year net asset growth rate.

Neuroscientific Biopharmaceuticals Ltd Capital Reinvestment Ratio by Year (2024–2024)

Neuroscientific Biopharmaceuticals Ltd capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see Neuroscientific Biopharmaceuticals Ltd (NSB) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2024	0.04x	AU$44.25K	AU$1.81K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow